| Protocols | ||
|---|---|---|
| 4 protocol(s) meet the specified criteria | ||
| Drug: LCV | ||
| Protocol No. | Title | Status |
| CALGB10403 | An Intergroup Phase II Clinical Trial for Adolescents and Young Adults with Untreated Acute Lymphoblastic Leukemia (ALL) | Open (affiliates only) |
| CALGB50403 | A Randomized Phase II Trial of Maintenance vs Consolidation Bortezomib Therapy Following Aggresive Chemo-Immunotherapy and Autologous Stem Cell Transplant for Previously Untreated Mantle Cell Lymphoma | Open (affiliates only) |
| CALGB80702 | A Phase III Trial of 6 versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer | Open (affiliates only) |
| E1910 | A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-negative B lineage Acute Lymphoblastic Leukemia in Adults. | Open |